AWS adds Chainlink oracle services to marketplace
Amazon Web Services has added Chainlink services to its AWS Marketplace, enabling enterprises to integrate blockchain data tools directly into cloud infrastructure.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Amazon Web Services has added Chainlink services to its AWS Marketplace, enabling enterprises to integrate blockchain data tools directly into cloud infrastructure.
Top holders of the Official Trump (TRUMP) memecoin are set to attend a private luncheon hosted by Donald Trump at his Mar-a-Lago property in Florida on Saturday.
Infini Resources (ASX:I88) secured essential exploration permits from the Saskatchewan Ministry of Energy and Resources.
Bellavista Resources (ASX:BVR) said that all conditions precedent for its acquisition of the Pickle Crow Gold Project have been officially satisfied or waived.
EVT (ASX:EVT) has released its trading update for the financial year ending June 30, projecting normalised EBITDA growth despite a volatile global landscape.
The Bank for International Settlements has warned that large crypto platforms now operate like banks and prime brokers without equivalent regulatory oversight.
Sensient Technologies (NYSE:SXT) reported a double-digit increase in both top and bottom-line results for the first quarter of 2026, fueled by broad-based demand across its global flavor, color, and specialty ingredient portfolios.
Norfolk Southern (NYSE:NSC) reported its first-quarter 2026 results on Friday, showcasing a resilient operating performance as efficiency gains helped the railroad offset a marginal decline in total shipping volumes.
HCA Healthcare (NYSE:HCA) posted a solid start to 2026, delivering a double-digit increase in earnings per share as steady patient volumes and operational "resiliency" initiatives helped the hospital giant navigate a complex reimbursement landscape.
Arrowhead Pharmaceuticals is on the verge of its first European commercial launch after regulatory advisors recommended the approval of its siRNA therapy, REDEMPLO, for a rare and potentially life-threatening lipid disorder.